Literature DB >> 22840620

A systematic review of cognitive remediation for schizo-affective and affective disorders.

Celia Anaya1, Anabel Martinez Aran, Jose L Ayuso-Mateos, Til Wykes, Eduard Vieta, Jan Scott.   

Abstract

BACKGROUND: Cognitive remediation is accepted as an important therapeutic intervention in schizophrenia, but few studies provide data on whether the benefits extend to affective disorders.
OBJECTIVES: To review quantitatively studies of cognitive remediation with samples that included cases of schizoaffective disorder, affective psychosis, unipolar and/or bipolar disorders.
METHODS: Twenty one studies met preliminary inclusion criteria, comprising a total of 940 participants of which 35% had an affective or schizoaffective disorder. Effect sizes (ES) for pre- to post-intervention change in cognitive performance were estimated.
RESULTS: A meta-analysis of 16 studies gave a pooled ES for change in cognitive function of 0.32 (95% Confidence Intervals 0.20 to 0.43) and produced statistical homogeneity. Overall, ES were significantly positively correlated with higher proportion of schizo-affective and affective cases (r=0.61; p=0.007), even when age, gender and duration of therapy were included as covariates in the analysis (r=.59, p=0.017). LIMITATIONS: The quality of and small number of affective disorder only studies mean the findings must be treated with caution.
CONCLUSIONS: The estimated ES reflect those reported in the literature on cognitive remediation for schizophrenia. As such a conservative interpretation is that cognitive remediation has at least equivalent benefits in affective and schizo-affective disorder as demonstrated in schizophrenia. Further studies are urgently required to examine the durability of any gains with cognitive remediation in affective populations and to determine if any changes in cognitive deficits lead to improvements in symptoms or functioning and/or whether post-intervention cognitive changes differ in character or magnitude from those reported in schizophrenia. Crown
Copyright © 2012. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22840620     DOI: 10.1016/j.jad.2012.04.020

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  26 in total

1.  A randomized controlled trial of cognitive remediation and work therapy in the early phase of substance use disorder recovery for older veterans: Neurocognitive and substance use outcomes.

Authors:  Morris D Bell; Holly B Laws; Ismene B Petrakis
Journal:  Psychiatr Rehabil J       Date:  2016-10-10

Review 2.  Treatment of Functional Impairment in Patients with Bipolar Disorder.

Authors:  Jose Sanchez-Moreno; Anabel Martinez-Aran; Eduard Vieta
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

3.  Compensatory cognitive training for people with severe mental illnesses in supported employment: A randomized controlled trial.

Authors:  Elizabeth W Twamley; Kelsey R Thomas; Cynthia Z Burton; Lea Vella; Dilip V Jeste; Robert K Heaton; Susan R McGurk
Journal:  Schizophr Res       Date:  2017-08-18       Impact factor: 4.939

Review 4.  S3 guideline on psychosocial therapies in severe mental illness: evidence and recommendations.

Authors:  Uta Gühne; Stefan Weinmann; Katrin Arnold; Thomas Becker; Steffi G Riedel-Heller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-11       Impact factor: 5.270

Review 5.  The management of cognitive impairment in bipolar disorder: current status and perspectives.

Authors:  Marsal Sanches; Isabelle E Bauer; Juan F Galvez; Giovana B Zunta-Soares; Jair C Soares
Journal:  Am J Ther       Date:  2015 Nov-Dec       Impact factor: 2.688

Review 6.  The effects of cognitive remediation in patients with affective psychosis: A systematic review: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.

Authors:  Bruno Biagianti; Jaisal Merchant; Paolo Brambilla; Kathryn E Lewandowski
Journal:  J Affect Disord       Date:  2019-03-08       Impact factor: 4.839

7.  The effects of cognitive remediation on cognitive abilities and real-world functioning among people with bipolar disorder: A systematic review: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.

Authors:  Marcella Bellani; Bruno Biagianti; Niccolò Zovetti; Maria Gloria Rossetti; Cinzia Bressi; Cinzia Perlini; Paolo Brambilla
Journal:  J Affect Disord       Date:  2019-07-19       Impact factor: 4.839

8.  Age as a moderator of change following compensatory cognitive training in individuals with severe mental illnesses.

Authors:  Kelsey R Thomas; Olga Puig; Elizabeth W Twamley
Journal:  Psychiatr Rehabil J       Date:  2016-08-22

9.  Memory performance predicts response to psychotherapy for depression in bipolar disorder: A pilot randomized controlled trial with exploratory functional magnetic resonance imaging.

Authors:  Thilo Deckersbach; Amy T Peters; Conor Shea; Aishwarya Gosai; Jonathan P Stange; Andrew D Peckham; Kristen K Ellard; Michael W Otto; Scott L Rauch; Darin D Dougherty; Andrew A Nierenberg
Journal:  J Affect Disord       Date:  2017-12-27       Impact factor: 4.839

Review 10.  Cognitive training in mental disorders: update and future directions.

Authors:  Matcheri S Keshavan; Sophia Vinogradov; Judith Rumsey; Joel Sherrill; Ann Wagner
Journal:  Am J Psychiatry       Date:  2014-05       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.